# Efficacy of a Non-invasive Vestibular System Masking for Improving Outcomes Following Acute Unilateral Vestibulopathy

> **NCT04226976** · NA · SUSPENDED · sponsor: **Otolith Labs** · enrollment: 40 (estimated)

## Conditions studied

- Dizziness
- Nausea

## Interventions

- **DEVICE:** Otoband
- **DEVICE:** Placebo Device

## Key facts

- **NCT ID:** NCT04226976
- **Lead sponsor:** Otolith Labs
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2022-06-01
- **Primary completion:** 2024-05-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 40 (ESTIMATED)
- **Why stopped:** COVID-19 general concerns
- **Last updated:** 2022-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04226976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04226976, "Efficacy of a Non-invasive Vestibular System Masking for Improving Outcomes Following Acute Unilateral Vestibulopathy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04226976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*